[go: up one dir, main page]

0% found this document useful (0 votes)
11 views23 pages

Mysterious Rash

The document presents a clinical case of a 35-year-old African American woman with a 3-month history of skin lesions, leading to a diagnosis of sarcoidosis characterized by non-caseating granulomas. Key findings include violaceous plaques on the face and arms, elevated serum ACE levels, and a mild restrictive pulmonary pattern. Treatment options range from topical steroids to systemic corticosteroids and TNF-alpha inhibitors, with a prognosis that varies based on the presence of specific symptoms and organ involvement.

Uploaded by

mr.thepro8081
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
11 views23 pages

Mysterious Rash

The document presents a clinical case of a 35-year-old African American woman with a 3-month history of skin lesions, leading to a diagnosis of sarcoidosis characterized by non-caseating granulomas. Key findings include violaceous plaques on the face and arms, elevated serum ACE levels, and a mild restrictive pulmonary pattern. Treatment options range from topical steroids to systemic corticosteroids and TNF-alpha inhibitors, with a prognosis that varies based on the presence of specific symptoms and organ involvement.

Uploaded by

mr.thepro8081
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 23

A Mysterious

Rash

Zokir Takhirov 190169


Clinical Case Presentation – The
Patient
• Case:
• A 35-year-old African American
woman presents with a 3-month
history of multiple skin
lesions on her face and arms.
• Mild cough and occasional
shortness of breath.
• No fever, weight loss, or systemic
symptoms.
• No history of similar lesions or
trauma.
Initial Dermatologic
Examination

• Multiple violaceous, indurated


plaques on the nose and cheeks.
• Several brownish-red papules on
the forearms.
• No pustules, vesicles, or ulcerations.
Differential Diagnosis of Papulonodular
Lesions

Granuloma annulare

Lupus
erythematosus

Sarcoidosis

Leprosy Cutaneous tuberculosis


Condition Clinical Clues Histology Other Tests

Red-brown papules/plaques, often on Non-caseating ↑ ACE, hypercalcemia,


Sarcoidosis
face or scars; lupus pernio (nose) granulomas CXR: hilar adenopathy

Lupus Basal vacuolar


Malar rash, photosensitivity, discoid ANA (+), anti-dsDNA
erythematos degeneration, perivascular
plaques (+)
us lymphocytes

Granuloma Annular, flesh-colored plaques, often Degenerated collagen, Self-limited, no


annulare on extremities palisading histiocytes systemic markers

Chronic ulcers, verrucous plaques; Caseating granulomas TB skin test (+), PCR,
Cutaneous TB
endemic areas with acid-fast bacilli culture

Hypopigmented anesthetic patches Granulomas with acid- Skin slit smear,


Leprosy
(tuberculoid), nodules (lepromatous) fast bacilli Lepromin test
Punch Excision
al

Skin Biopsy
A biopsy of the papular lesion was performed.
Biopsy results
•Histopathology: Non-caseating
granulomas in the dermis without
central necrosis.
•Negative for fungal or mycobacterial
organisms.
Systemic • Pulmonary function tests: Mild
restrictive pattern.

Evaluation
Lab tests
•↑ Serum ACE – Due to granuloma-associated
macrophages.
•Hypercalcemia & Hypercalciuria – Macrophages in
granulomas produce 1α-hydroxylase, increasing
vitamin D activation.
•↑ Alkaline phosphatase (ALP) – If liver involvement is
present.
•↓ Lymphocyte count (Lymphopenia) – Due to
sequestration in granulomas.
•↑ CD4/CD8 ratio in bronchoalveolar lavage (BAL)
(>3.5)
Sarcoidosis!
Sarcoidosis
Definition: Chronic granulomatous disease
of unknown etiology, characterized by non-
caseating granulomas in multiple organs.

Pathophysiology:
• Immune dysregulation: Exaggerated Th1
response → ↑ IFN-γ & TNF-α → macrophage
activation → granuloma formation.
• Non-caseating granulomas: Composed of
epithelioid macrophages, multinucleated
giant cells, and lymphocytes.
Sarcoidosis Subtypes in
Dermatology

Plaque
sarcoidosis

Papular sarcoidosis – Most Lupus pernio – Chronic, disfiguring


common; brown-red papules on plaques on the nose, cheeks, and ears.
the face and trunk.

Erythema nodosum –
Tender subcutaneous
nodules on the legs
(often self-limited). •Scar sarcoidosis – Old scars
Subcutaneous Nodular
sarcoidosis become raised and inflamed. sarcoidosis
Treatment Options
•First-line:
Topical/intralesional
steroids.
•Severe cases: Systemic
corticosteroids (prednisone).
•Steroid-sparing agents:
Methotrexate,
hydroxychloroquine.
•Refractory cases: TNF-
alpha inhibitors (infliximab).
 Cutaneous sarcoidosis may resolve
spontaneously or persist.

Prognosis  Lupus pernio = worse prognosis


(associated with chronic pulmonary disease).
 Spontaneous resolution: ~60% of cases,
especially with isolated hilar adenopathy.
 Chronic disease: ~30%, with progressive
fibrosis in lungs or other organs.
 Severe complications: ~10%, including
pulmonary hypertension, cardiac involvement,
or neurosarcoidosis.
 Mortality: ~1-5%, mainly from respiratory
failure, cardiac arrhythmias, or CNS disease.
Skin findings can be the
first clue to systemic
Final sarcoidosis.
Always biopsy suspicious
Takeawa lesions to confirm
ys & granulomas.
Rule out TB and
Discussio infections before
n diagnosing sarcoidosis.
Multidisciplinary approach:
Dermatology +
Pulmonology.
Definition: Chronic granulomatous disease of unknown etiology, Cardiac Manifestations (5%)
characterized by non-caseating granulomas in multiple organs.
• Conduction abnormalities: AV block is most common.

Pathophysiology: • Restrictive or dilated cardiomyopathy.

• Immune dysregulation: Exaggerated Th1 response → ↑ IFN-γ &


TNF-α → macrophage activation → granuloma formation. Neurologic Manifestations (5-10%)

• Non-caseating granulomas: Composed of epithelioid • Facial nerve palsy (Bell’s palsy).


macrophages, multinucleated giant cells, and lymphocytes. • Meningitis, seizures, or peripheral neuropathy.

Pulmonary Manifestations (Most Common, ~90%) Other Systemic Features


• Bilateral hilar lymphadenopathy (BHL): Classic CXR finding. • Löfgren syndrome: BHL, erythema nodosum, fever,
• Interstitial lung disease: Reticular opacities, fibrosis (restrictive polyarthritis (good prognosis).
pattern). • Heerfordt syndrome: Uveitis, parotitis, fever, facial nerve
• Hypercalcemia: Due to increased 1α-hydroxylase in palsy.
granulomas → ↑ 1,25-(OH)₂D.
Diagnosis:

Dermatologic Manifestations (30%) • CXR: BHL, interstitial lung disease.

• Lupus pernio: Violaceous plaques on nose, cheeks, ears • Serum ACE ↑ (nonspecific).
(specific for sarcoidosis). • Hypercalcemia (↑ 1,25-vitamin D).
• Erythema nodosum: Tender red nodules on shins (good • Biopsy: Non-caseating granulomas (gold standard).
prognosis, often self-limiting).
• Maculopapular lesions: Common but non-specific. Treatment:
• Asymptomatic or mild cases: Observation.
Ophthalmologic Manifestations (25%)
• Symptomatic (lungs, eyes, heart, neuro): Corticosteroids
• Uveitis: Blurred vision, photophobia, conjunctival granulomas. are first-line.
• Sicca syndrome: Lacrimal gland involvement → dry eyes. • Refractory cases: Methotrexate, TNF-α inhibitors
Summary
A: Waxy interscapular skin plaques – cutaneous
sarcoidosis.
B: Lupus pernio – violaceous facial plaques, a chronic
sarcoidosis feature.
C: Anterior uveitis with synechiae – ocular
involvement, common in sarcoidosis.
D: Enlarged, nodular lacrimal gland – sarcoid-related
lacrimal gland involvement.
E: Endobronchial cobblestoning – bronchial sarcoidosis.
F: Peripheral facial-nerve palsy with hearing loss –
Heerfordt syndrome.
G: Spinal cord mass – neurosarcoidosis.
H: Multi-organ involvement on gallium scan –
sarcoidosis distribution.
I: Hypermetabolic liver, spleen, and lymph nodes – PET
scan of sarcoidosis.
J: Aspergilloma in lung cavity – sarcoid-associated
fungal colonization.
K: Hypodense splenic nodules – splenic sarcoidosis.
L: Optic chiasm involvement – neurosarcoidosis with
visual risk.
M: Granulomatous humeral lesion – bone sarcoidosis.
Summary of sarcoidosis
Reference
1. AE Lopez-Sundh, T Maestre-Orozco, MC Gonzalez-Vela, & M Fernandez-Ayala. (2021). Subcutaneous sarcoidosis. Journal of Postgraduate Medicine, 67(3), 154–157.
https://doi.org/10.4103/jpgm.jpgm_1072_20
2. Dr. Aye Min Htoo. (2021, November 28). Dr. Aye Min Htoo - Dermatologist & Author. https://drayeminhtoo.com/lupus-vulgaris/
3. Girod, B., & Crowley, K. (2023a, July 31). Leprosy could become endemic to Florida. Here is what to know. USA TODAY; Pensacola News Journal.
https://www.usatoday.com/story/news/health/2023/07/31/leprosy-florida-outbreak-symptoms-causes/70499618007/
4. Girod, B., & Crowley, K. (2023b, July 31). Leprosy could become endemic to Florida. Here is what to know. USA TODAY; Pensacola News Journal.
https://www.usatoday.com/story/news/health/2023/07/31/leprosy-florida-outbreak-symptoms-causes/70499618007/
5. Hudson, M. (2017, July 21). The Stages of Pulmonary Sarcoidosis- What Do They Really Mean? Foundation for Sarcoidosis Research. https://www.stopsarcoidosis.org/stages-of-
sarcoidosis/
6. Pasquali, P., Gonzalez, S., Fortuño, A., & Azael Freites-Martinez. (2019). In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy. Anais Brasileiros
de Dermatologia, 94(1), 93–95. https://doi.org/10.1590/abd1806-4841.20197315
7. Pathology of Lupus Vulgaris (Cutaneous Tuberculosis) - Dr Sampurna Roy MD. (2022). Histopathology-India.net. https://www.histopathology-india.net/lupus_vulgaris.htm
8. Rodrigues, T., Rocha, E., & Barcelos, A. (2017). Ocular and parotid sarcoidosis - panda sign. Acta Reumatológica Portuguesa; https://www.semanticscholar.org/paper/Ocular-and-
parotid-sarcoidosis-panda-sign.-Rodrigues-Rocha/2203e280bc3e5f4c775d68b35c9bf2ff88ea4771
9. Sarcoidosis, Erythema Nodosum – Sleep and Lung Care. (2018, September 24). Sleepandlungcare.com.au. https://sleepandlungcare.com.au/lung-cancer-the-basics/sarcoidosis-erythema-
nodosum/
10. Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., & El Jammal, T. (2021). Sarcoidosis: A Clinical
Overview from Symptoms to Diagnosis. Cells, 10(4), 766. https://doi.org/10.3390/cells10040766
11. Sifuentes, A. (2024a, March 14). Linkedin.com. https://www.linkedin.com/posts/w-alberto-sifuentes-giraldo-7213997b_sarcoidosis-activity-7174033726975180800-m-Qa
12. Sifuentes, A. (2024b, March 14). Linkedin.com. https://www.linkedin.com/posts/w-alberto-sifuentes-giraldo-7213997b_sarcoidosis-activity-7174033726975180800-m-Qa
13. Singh, S., Sharma, B. B., Mohan Bairwa, Dipti Gothi, & Raghu, G. (2020). Management of Interstitial Lung Diseases: A consensus statement of the Indian Chest Society (ICS) and
National College of Chest Physicians (NCCP ). Lung India, 37(4), 360–374.
https://www.researchgate.net/publication/342623307_Management_of_Interstitial_Lung_Diseases_A_consensus_statement_of_the_Indian_Chest_Society_ICS_and_National_College_
of_Chest_Physicians_NCCP
14. Stagaki, E., Mountford, W. K., Lackland, D. T., & Judson, M. A. (2008). The Treatment of Lupus Pernio. CHEST Journal, 135(2), 468–476. https://doi.org/10.1378/chest.08-1347
15. (2020). Jcdr.net. https://www.jcdr.net/ReadXMLFile.aspx?id=14009
16. (2025a). Amboss.com. https://media-us.amboss.com/media/thumbs/big_6638e96fa54049.74654041.jpg
17. (2025b). Mbscf.com. https://media-us.mbscf.com/media/thumbs/big_5dfa49d483e12.jpg
18. (2025c). Sarcoidosisnews.com. https://sarcoidosisnews.com/wp-content/uploads/2019/11/shutterstock_570694897_zpscj873mxl-1200x900-cropped.jpg
19. (2025d). Sciencephoto.com. https://media.sciencephoto.com/c0/52/20/29/c0522029-800px-wm.jpg
20. (2025e). Grepmed.com. https://img.grepmed.com/uploads/9187/syndrome-diagnosis-lofgren-original.jpeg
21. Gerke, A. K. (2020). Treatment of Sarcoidosis: A Multidisciplinary Approach. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.545413
22. Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. New England Journal of Medicine, 357(21), 2153–2165. https://doi.org/10.1056/nejmra071714

You might also like